Please login to the form below

Not currently logged in
Email:
Password:

Caudex Medical makes senior hires

Appoints Andy Bowman and Gary Burd

Caudex Medical has appointed Andy Bowman as its new global head and Gary Burd as director of scientific services.

Bowman joins the Oxford, UK-based medical education agency from the Choice Group where he was CEO of Choice Healthcare Solutions and, latterly, vice chairman of the Choice Group.

Initially qualifying as a microbiologist, Bowman moved into pharmaceutical sales and then training. He now has over 20 years' pharmaceutical company and agency experience on global and local stages.

Caudex Medical - Andy BowmanCaudex Medical - Gary Burd
Andy Bowman and Gary Burd

Meanwhile, Gary Burd joins Caudex Medical from Complete HealthVizion, where he worked for five years, initially as an editorial team leader and then a scientific director. Prior to this Gary spent three years as an editorial projects manager at Parexel.

3rd February 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Attigo (part of the Mednet Group)

Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...

Latest intelligence

New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021....
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs....
5 steps to effective clinical trial branding
When recruiting patients for your clinical trial, you want the materials and information around it to be seen as reputable and professional. To make it clear what the clinical trial...

Infographics